99 related articles for article (PubMed ID: 17922523)
1. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases.
Rades D; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Nov; 110(10):2285-92. PubMed ID: 17922523
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery.
Bian SX; Routman D; Liu J; Yang D; Groshen S; Zada G; Trakul N; Wong MK; Yu C; Chang EL
J Neurosurg; 2016 Dec; 125(Suppl 1):31-39. PubMed ID: 27903181
[TBL] [Abstract][Full Text] [Related]
3. Glasgow prognostic score for assessing the efficacy of whole-brain radiation therapy in cases of recursive partitioning analysis class 2 and class 3 multiple brain metastases: a retrospective study.
Ishikawa Y; Umezawa R; Yamamoto T; Takahashi N; Takeda K; Suzuki Y; Kishida K; Omata S; Teramura S; Ito K; Yamada T; Jingu K
Acta Neurol Belg; 2024 Feb; 124(1):231-239. PubMed ID: 37747688
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis.
Meyners T; Heisterkamp C; Kueter JD; Veninga T; Stalpers LJ; Schild SE; Rades D
BMC Cancer; 2010 Oct; 10():582. PubMed ID: 20977700
[TBL] [Abstract][Full Text] [Related]
5. Local Control and Survival Outcomes After Stereotactic Radiosurgery for Brain Metastases From Gastrointestinal Primaries: An International Multicenter Analysis.
Singh R; Bowden G; Mathieu D; Perlow HK; Palmer JD; Elhamdani S; Shepard M; Liang Y; Nabeel AM; Reda WA; Tawadros SR; Abdelkarim K; El-Shehaby AMN; Emad RM; Elazzazi AH; Warnick RE; Gozal YM; Daly M; McShane B; Addis-Jackson M; Karthikeyan G; Smith S; Picozzi P; Franzini A; Kaisman-Elbaz T; Yang HC; Wei Z; Legarreta A; Hess J; Templeton K; Pikis S; Mantziaris G; Simonova G; Liscak R; Peker S; Samanci Y; Chiang V; Niranjan A; Kersh CR; Lee CC; Trifiletti DM; Lunsford LD; Sheehan JP
Neurosurgery; 2023 Sep; 93(3):592-598. PubMed ID: 36942965
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic radiosurgery for single brain metastases from non-small cell lung cancer: progression of extracranial disease correlates with distant intracranial failure.
Kress MA; Oermann E; Ewend MG; Hoffman RB; Chaudhry H; Collins B
Radiat Oncol; 2013 Mar; 8():64. PubMed ID: 23510318
[TBL] [Abstract][Full Text] [Related]
7. Concomitant radiosurgical and targeted oncological treatment improves the outcome of patients with brain metastases from gastrointestinal cancer.
Khalaveh F; Cho A; Shaltout A; Untersteiner H; Kranawetter B; Hirschmann D; Göbl P; Marik W; Gatterbauer B; Rössler K; Dorfer C; Frischer JM
Radiat Oncol; 2023 Dec; 18(1):197. PubMed ID: 38071299
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Gamma Knife Radiosurgery for Brain Metastases in the Motor Cortex.
Prasad S; Alzate JD; Mullen R; Bernstein K; Qu T; Silverman J; Kondziolka D
Neurosurgery; 2024 Mar; 94(3):606-613. PubMed ID: 37823677
[TBL] [Abstract][Full Text] [Related]
9. Incidence and clinical profile of brain metastasis treated with whole brain radiotherapy in a tertiary hospital in eastern India: A retrospective audit.
Sammaddar D; Basu A; Roy P; Chowdhury H
Indian J Cancer; 2023; 60(3):337-344. PubMed ID: 36861704
[TBL] [Abstract][Full Text] [Related]
10. Clinical analysis of novalis stereotactic radiosurgery for brain metastases.
Gu HW; Sohn MJ; Lee DJ; Lee HR; Lee CH; Whang CJ
J Korean Neurosurg Soc; 2009 Sep; 46(3):245-51. PubMed ID: 19844626
[TBL] [Abstract][Full Text] [Related]
11. Survival and Radiation Dose Differences Between Single Versus Multi-Session Gamma Knife Stereotactic Radiosurgery in Patients Treated for Multiple (≥10) Brain Metastases.
Stambaugh C; Wang AY; Kim E; Mignano JE; Melhus CS; Rodrigues R; Huber K; Stambaugh N; Wu J
Cureus; 2023 Oct; 15(10):e46901. PubMed ID: 37954747
[TBL] [Abstract][Full Text] [Related]
12. Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases - Clinical outcome and prognostic factors.
Hahnemann L; Krämer A; Fink C; Jungk C; Thomas M; Christopoulos P; Lischalk JW; Meis J; Hörner-Rieber J; Eichkorn T; Deng M; Lang K; Paul A; Meixner E; Weykamp F; Debus J; König L
Clin Transl Radiat Oncol; 2024 May; 46():100782. PubMed ID: 38694237
[TBL] [Abstract][Full Text] [Related]
13. Estimating prognosis at the time of repeat whole brain radiation therapy for multiple brain metastases: The reirradiation score.
Logie N; Jimenez RB; Pulenzas N; Linden K; Ciafone D; Ghosh S; Xu Y; Lefresne S; Wong E; Son CH; Shih HA; Wong WW; Tyldesley S; Dennis K; Chow E; Fairchild AM
Adv Radiat Oncol; 2017; 2(3):381-390. PubMed ID: 29114606
[TBL] [Abstract][Full Text] [Related]
14. Time to administration of stereotactic radiosurgery to the cavity after surgery for brain metastases: a real-world analysis.
Roth O'Brien DA; Kaye SM; Poppas PJ; Mahase SS; An A; Christos PJ; Liechty B; Pisapia D; Ramakrishna R; Wernicke AG; Knisely JPS; Pannullo SC; Schwartz TH
J Neurosurg; 2021 May; 135(6):1695-1705. PubMed ID: 34049277
[TBL] [Abstract][Full Text] [Related]
15. Surgery for brain metastases: radiooncology scores predict survival-score index for radiosurgery, graded prognostic assessment, recursive partitioning analysis.
Wolfert C; Rohde V; Hussein A; Fiss I; Hernández-Durán S; Malzahn D; Bleckmann A; Mielke D; Schatlo B
Acta Neurochir (Wien); 2023 Jan; 165(1):231-238. PubMed ID: 36152217
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors and Impact of Therapeutic Intervention in Patients With Brain Metastases at the Initial Presentation.
Ishikawa Y; Teramura S; Nakano H; Ito K; Yamada T
Cureus; 2024 May; 16(5):e60368. PubMed ID: 38751406
[TBL] [Abstract][Full Text] [Related]
17. Prognosis versus Actual Outcomes in Stereotactic Radiosurgery of Brain Metastases: Reliability of Common Prognostic Parameters and Indices.
Mangesius J; Seppi T; Arnold CR; Mangesius S; Kerschbaumer J; Demetz M; Minasch D; Vorbach SM; Sarcletti M; Lukas P; Nevinny-Stickel M; Ganswindt U
Curr Oncol; 2024 Mar; 31(4):1739-1751. PubMed ID: 38668035
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated and single-fraction radiosurgery for brain metastases with sex as a key predictor of overall survival.
Mangesius J; Seppi T; Bates K; Arnold CR; Minasch D; Mangesius S; Kerschbaumer J; Lukas P; Ganswindt U; Nevinny-Stickel M
Sci Rep; 2021 Apr; 11(1):8639. PubMed ID: 33883632
[TBL] [Abstract][Full Text] [Related]
19. A Bayesian network meta-analysis of whole brain radiotherapy and stereotactic radiotherapy for brain metastasis.
Yuan X; Liu WJ; Li B; Shen ZT; Shen JS; Zhu XX
Medicine (Baltimore); 2017 Aug; 96(34):e7698. PubMed ID: 28834873
[TBL] [Abstract][Full Text] [Related]
20. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.
Linskey ME; Andrews DW; Asher AL; Burri SH; Kondziolka D; Robinson PD; Ammirati M; Cobbs CS; Gaspar LE; Loeffler JS; McDermott M; Mehta MP; Mikkelsen T; Olson JJ; Paleologos NA; Patchell RA; Ryken TC; Kalkanis SN
J Neurooncol; 2010 Jan; 96(1):45-68. PubMed ID: 19960227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
